A spliced form of CD44 expresses the unique glycan that is recognized by the prostate cancer specific antibody F77

Prostate cancer is the most common cancer occurring in men in the United States. The monoclonal antibody F77 that was originally developed in our laboratory recognizes mainly glycolipids as well as O-linked glycosylation on proteins in prostate cancer cells. We have identified a spliced form of glyc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Chen, Xi, Nagai, Yasuhiro, Zhu, Zhiqiang, Ruan, Hang, Peehl, Donna M., Greene, Mark I., Zhang, Hongtao
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5790488/
https://ncbi.nlm.nih.gov/pubmed/29423071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23341
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados